Atria Wealth Solutions Inc. Has $2.03 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Atria Wealth Solutions Inc. lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 3,421 shares of the biotechnology company’s stock after selling 140 shares during the period. Atria Wealth Solutions Inc.’s holdings in Axon Enterprise were worth $2,033,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in AXON. Asset Dedication LLC boosted its stake in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after buying an additional 18 shares during the last quarter. Bleakley Financial Group LLC grew its holdings in shares of Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after acquiring an additional 20 shares in the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after acquiring an additional 21 shares in the last quarter. Insigneo Advisory Services LLC grew its holdings in shares of Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after acquiring an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC grew its holdings in shares of Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after acquiring an additional 24 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Robert W. Baird upped their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Trading Down 5.3 %

NASDAQ:AXON opened at $513.22 on Friday. The company has a market cap of $39.13 billion, a P/E ratio of 132.62, a P/E/G ratio of 5.43 and a beta of 1.05. The stock’s fifty day moving average price is $619.94 and its two-hundred day moving average price is $518.66. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insiders Place Their Bets

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the transaction, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock worth $5,631,561 over the last 90 days. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.